Locally Advanced Prostate Cancer Treated With Concomitant Radiation and 5-Fluorouracil: Southwest Oncology Group Study 9024

The Journal of Urology ◽

10.1016/j.juro.2006.03.068 ◽

2006 ◽

Vol 176 (2) ◽

pp. 548-553 ◽

Author(s):

Gregory P. Swanson ◽

James Faulkner ◽

Stephen R. Smalley ◽

Mark J. Noble ◽

Ronald L. Stephens ◽

...

Keyword(s):

Prostate Cancer ◽

Advanced Prostate Cancer ◽

Locally Advanced ◽

Oncology Group ◽

Locally Advanced Prostate Cancer ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

Southwest Oncology Group Study

Download Full-text

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)

Urology ◽

10.1016/s0090-4295(01)01010-x ◽

2001 ◽

Vol 58 (1) ◽

pp. 53-58 ◽

Author(s):

Omer Kucuk ◽

Emily Fisher ◽

Carol M Moinpour ◽

Dorothy Coleman ◽

Maha H.A Hussain ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Hormonal Therapy ◽

Advanced Prostate Cancer ◽

Phase Ii Trial ◽

Oncology Group ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

Southwest Oncology Group Study

Download Full-text

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: Results of a phase II Southwest Oncology Group study

Lung Cancer ◽

10.1016/0169-5002(95)99026-e ◽

1995 ◽

Vol 12 (3) ◽

pp. 324

Keyword(s):

Low Dose ◽

Locally Advanced ◽

High Dose ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

Thoracic Irradiation ◽

Southwest Oncology Group Study

Download Full-text

Epothilone B (Epo-B) analogue BMS-247550 (NSC #710428) administered every 21 days in patients (pts) with hormone refractory prostate cancer (HRPC). A Southwest Oncology Group Study (S0111)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4510 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4510-4510 ◽

Author(s):

M. Hussain ◽

J. Faulkner ◽

U. Vaishampayan ◽

P. Lara ◽

D. Petrylak ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Refractory Prostate Cancer ◽

Oncology Group ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

Epothilone B ◽

Southwest Oncology Group Study ◽

Hormone Refractory

Download Full-text

COMBINATION CISPLATIN, 5-FLUOROURACIL AND RADIATION THERAPY FOR LOCALLY ADVANCED UNRESECTABLE OR MEDICALLY UNFIT BLADDER CANCER CASES: A SOUTHWEST ONCOLOGY GROUP STUDY

The Journal of Urology ◽

10.1097/00005392-200101000-00014 ◽

2001 ◽

Vol 165 (1) ◽

pp. 56-61 ◽

Author(s):

MAHA H.A. HUSSAIN ◽

TRACY R. GLASS ◽

JEFFREY FORMAN ◽

WAEL SAKR ◽

DAVID C. SMITH ◽

...

Keyword(s):

Bladder Cancer ◽

Radiation Therapy ◽

Locally Advanced ◽

Oncology Group ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

Southwest Oncology Group Study

Download Full-text

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(05)70348-x ◽

2005 ◽

Vol 6 (11) ◽

pp. 841-850 ◽

Author(s):

James W Denham ◽

Allison Steigler ◽

David S Lamb ◽

David Joseph ◽

Hedy Mameghan ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Oncology ◽

Advanced Prostate Cancer ◽

Controlled Trial ◽

Locally Advanced ◽

Oncology Group ◽

Locally Advanced Prostate Cancer ◽

Radiation Oncology Group ◽

Randomised Controlled

Download Full-text

Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109

Urology ◽

10.1016/j.urology.2011.11.019 ◽

2012 ◽

Vol 79 (3) ◽

pp. 633-637 ◽

Author(s):

Ryan K. Berglund ◽

Catherine M. Tangen ◽

Isaac J. Powell ◽

Bruce A. Lowe ◽

Gabriel P. Haas ◽

...

Keyword(s):

Prostate Cancer ◽

Radical Prostatectomy ◽

Neoadjuvant Therapy ◽

Oncology Group ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

Southwest Oncology Group Study ◽

Goserelin Acetate

Download Full-text

Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610

Radiation Oncology ◽

10.1186/1748-717x-8-100 ◽

2013 ◽

Vol 8 (1) ◽

Author(s):

Larry Pan ◽

Seunghee Baek ◽

Pamela R Edmonds ◽

Mack Roach ◽

Harvey Wolkov ◽

...

Keyword(s):

Prostate Cancer ◽

Advanced Prostate Cancer ◽

Locally Advanced ◽

Radiation Therapy Oncology Group ◽

Secondary Analysis ◽

Vascular Endothelial ◽

Oncology Group ◽

Vegf Expression ◽

Locally Advanced Prostate Cancer ◽

Endothelial Growth Factor

Download Full-text

Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A southwest oncology group study

Annals of Surgical Oncology ◽

10.1007/bf02307081 ◽

1995 ◽

Vol 2 (6) ◽

pp. 488-494 ◽

Author(s):

John S. Macdonald ◽

Thomas R. Fleming ◽

Robert F. Peterson ◽

Jeffrey L. Berenberg ◽

Suzanne McClure ◽

...

Keyword(s):

Adjuvant Chemotherapy ◽

Mitomycin C ◽

Gastric Adenocarcinoma ◽

Locally Advanced ◽

Oncology Group ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

Southwest Oncology Group Study ◽

Advanced Gastric Adenocarcinoma

Download Full-text

Three-month change in PSA as a surrogate endpoint for mortality in advanced hormone-refractory prostate cancer (HRPC): Data from Southwest Oncology Group Study S9916

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4505 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4505-4505 ◽

Author(s):

E. D. Crawford ◽

D. K. Pauler ◽

C. M. Tangen ◽

M. H. A. Hussain ◽

E. J. Small ◽

...

Keyword(s):

Prostate Cancer ◽

Surrogate Endpoint ◽

Hormone Refractory Prostate Cancer ◽

Oncology Group ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

Southwest Oncology Group Study ◽

Hormone Refractory

Download Full-text

Three-month change in PSA as a surrogate endpoint for mortality in advanced hormone-refractory prostate cancer (HRPC): Data from Southwest Oncology Group Study S9916

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4505 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4505-4505

Author(s):

E. D. Crawford ◽

D. K. Pauler ◽

C. M. Tangen ◽

M. H. A. Hussain ◽

E. J. Small ◽

...

Keyword(s):

Prostate Cancer ◽

Surrogate Endpoint ◽

Hormone Refractory Prostate Cancer ◽

Oncology Group ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

Southwest Oncology Group Study ◽

Hormone Refractory

Download Full-text